ANTHONY C HOOPER Insider Trading $BMY BRISTOL MYERS SQUIBB CO

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANTHONY C HOOPER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANTHONY C HOOPER. ANTHONY C HOOPER is EVP, Global Commercial Ops. in AMGEN INC ($AMGN) and President US Pharmaceuticals in BRISTOL MYERS SQUIBB CO ($BMY) and Director in MANNKIND CORP ($MNKD) and Director in BeiGene, Ltd. ($BGNE).

Over the past year ANTHONY C HOOPER has been an insider in 2 companies. The total value of shares held by ANTHONY C HOOPER in these companies amounts to $64,363.

ANTHONY C HOOPER EVP, Global Commercial Ops.
AMGEN INC
Director
BeiGene, Ltd.
President US Pharmaceuticals
BRISTOL MYERS SQUIBB CO
Director
MANNKIND CORP
$ 64363 The total value of shares held by ANTHONY C HOOPER
Insider Rank

ANTHONY C HOOPER ranks 31,821 out of 350,000 insiders. Go to Insider Ranking to see more.

ANTHONY C HOOPER in BRISTOL MYERS SQUIBB CO

Trading Symbol: BMY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANTHONY C HOOPER: President US Pharmaceuticals
Holdings: 102,331 shares
Current Value: $5,286,419
Latest Transaction: Mar 06 2008
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ANTHONY C HOOPER in BRISTOL MYERS SQUIBB CO

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMGN, BGNE, BMY, MNKD

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 06 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA0.0013,077013,077
Mar 06 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA22.14171,4953,796,899171,495
Mar 04 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF22.611,17826,635102,331103.5 K to 102.3 K (-1.14 %)
Mar 04 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF22.611,03823,469103,509104.5 K to 103.5 K (-0.99 %)
Sep 12 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF0.003,8710104,558108.4 K to 104.6 K (-3.57 %)
Jun 21 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF31.232,43175,92095,54998 K to 95.5 K (-2.48 %)
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseM28.9030,000867,0000
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF30.1244313,34397,98098.4 K to 98 K (-0.45 %)
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF30.1228,785867,00498,423127.2 K to 98.4 K (-22.63 %)
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...BuyM28.9030,000867,000127,20897.2 K to 127.2 K (+30.86 %)
Jun 22 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF25.482,43161,942113,165115.6 K to 113.2 K (-2.10 %)
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA22.7378,7501,789,98878,750
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF22.731,86242,323115,596117.5 K to 115.6 K (-1.59 %)
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA22.735,107116,082117,458112.4 K to 117.5 K (+4.55 %)
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA22.7318,900429,597112,35193.5 K to 112.4 K (+20.22 %)
Jul 12 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF24.8263915,86068,45169.1 K to 68.5 K (-0.92 %)
Sep 21 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA0.0025,000093,45168.5 K to 93.5 K (+36.52 %)
Jun 22 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF0.002,430069,09071.5 K to 69.1 K (-3.40 %)
Mar 03 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA25.4555,8331,420,95055,833
Mar 03 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA0.009,306071,52062.2 K to 71.5 K (+14.96 %)
Jul 12 2004BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF24.1958714,20062,21462.8 K to 62.2 K (-0.93 %)
Mar 04 2004BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA28.1163,3331,780,29163,333
Mar 04 2004BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA0.0010,556062,80152.2 K to 62.8 K (+20.20 %)

Page:   1